EUVIMED · CrossrefJournal
Experimental Hematology & Oncology
ISSN 2162-3619 · Springer Science and Business Media LLC
Latest articles
A targetable SWI/SNF dependency sustains survival in pediatric B-ALL
Fibroblast-derived MDK promotes Lymph node metastasis in Luminal Breast Cancer through an SDC4-USP9X-RELB deubiquitination axis
RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis
CAR immunotherapy for cancer: from ex vivo manufacturing to in vivo immune cell engineering
A non-IMiD multi-target degrader reactivates fetal hemoglobin
Subtype-resolved tumor-intrinsic programs in immune-cold breast cancer: mechanistic interactions, evidence gaps, and translational priorities
Dismantling the immune-metabolic barrier in TP53-mutant hematologic malignancies
Distinct asciminib sensitivity profiles between BCR::ABL1 p190 and p210 isoforms
Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer
SCGB3A2 marks a low-angiogenesis tumor cell state associated with extracellular PGK2 and angiostatin in lung adenocarcinoma
HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation
Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study
Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation
Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design
Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis
Targeting SLC6A14-mediated nutrient competition reverses an immunosuppressive metabolic niche in pancreatic cancer
Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma
Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series
Cellular adhesion-dependent 3D morphogenesis indicating brain tumor aggressiveness and chemosensitivity in spherical cavity culture
AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models
The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity
Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs
Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting
Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK+ ALCL
Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion
Frontline T cell-redirecting therapies in newly diagnosed multiple myeloma: key signals from the 2025 ASH Annual Meeting
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study
Role of methionine metabolism in cancer: recent advances in molecular mechanisms and therapeutic implications
Targeting the cancer metabolism—immunity interface: update and perspectives
EUVIMED